FEDELE, DOMENICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.425
EU - Europa 449
AS - Asia 317
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 5.193
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.424
CN - Cina 216
FI - Finlandia 115
DE - Germania 104
VN - Vietnam 95
UA - Ucraina 94
IT - Italia 46
SE - Svezia 37
GB - Regno Unito 29
FR - Francia 12
IE - Irlanda 7
IN - India 5
NL - Olanda 2
BE - Belgio 1
BO - Bolivia 1
CZ - Repubblica Ceca 1
EU - Europa 1
MY - Malesia 1
PA - Panama 1
PL - Polonia 1
Totale 5.193
Salva come PNG Salva come JPEG
Città #
Fairfield 667
Jacksonville 482
Woodbridge 434
Chandler 433
Houston 322
Ann Arbor 310
Ashburn 306
Wilmington 277
Cambridge 233
Seattle 212
Princeton 136
Dong Ket 95
Roxbury 71
San Diego 69
Des Moines 52
Nanjing 50
Helsinki 41
Beijing 29
Boardman 29
Shenyang 23
Guangzhou 19
Medford 19
Nanchang 18
Changsha 15
Hebei 12
Washington 12
Jinan 10
Padova 10
Jiaxing 9
Norwalk 9
Falls Church 8
Hangzhou 8
Tianjin 8
Castel Maggiore 7
New York 7
Detroit 6
Dublin 6
Indiana 5
Maintal 5
Nürnberg 5
Redwood City 5
Ardea 4
Dearborn 4
Kilburn 4
London 4
Milan 4
Lanzhou 3
Chicago 2
Guidizzolo 2
Kharkiv 2
Los Angeles 2
Ningbo 2
Phoenix 2
Taiyuan 2
Acton 1
Auburn Hills 1
Borås 1
Brendola 1
Brno 1
Campodarsego 1
Cochabamba 1
Easton 1
Geislingen an der Steige 1
Henderson 1
Hounslow 1
Kunming 1
Lappeenranta 1
Le Casine-Perignano-Spinelli 1
New Bedfont 1
Palermo 1
Panama City 1
Puchong 1
Pune 1
Rockville 1
Rome 1
San Francisco 1
Sassari 1
Simi Valley 1
Taizhou 1
Tappahannock 1
Trecenta 1
Vicenza 1
Yellow Springs 1
Zhengzhou 1
Totale 4.541
Salva come PNG Salva come JPEG
Nome #
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 160
The complexity of non-enzymatic glycation product sets of human globins 142
Advanced glycation end products and antioxidant status in type 2 diabetic patients with and without peripheral artery disease 128
An effective derivatization method for quantitative determination of glyoxal and methylglyoxal in plasma samples by gas chromatography/mass spectrometry 128
Standing to lying heart rate variation. A new simple test in the diagnosis of diabetic autonomic neuropathy. 114
The effects of psyllium on lipoproteins in type II diabetic patients 108
Desaturase activities and metabolic control in type 2 diabetes 105
Enzymatic digestion and mass spectrometry in the study of advanced glycation end products/peptides 104
AGE in micro- and macroangiopathy 103
Prolonged QT period in diabetic autonomic neuropathy: a possible role in sudden cardiac death ? 102
Relationship between glyco-oxidation, antioxidant status and microalbuminuria in type 2 diabetic patients 99
Translating the A1C assay into estimated average glucose values 98
Subclinical diastolic dysfunction in type 2 diabetic patients with and without carotid atherosclerosis: Relationship with glyco-oxidation, lipid-oxidation and antioxidant status. 94
The complexity of non-enzymatic glycation product sets of human globins 93
Long-term treatment with simvastatin in hypercholesterolemic non-insulin- dependent diabetic patients 89
Management of gestational diabetes mellitus. 89
Elevations of inflammatory cytokines during and after pregnancy in gestational diabetes 88
Analysis of outcome of pregnancy in type 1 diabetics treated with insulin pump or conventional insulin therapy 87
Pregnancy outcome in immigrant women with gestational diabetes mellitus 85
Autoantibodies against oxidized LDLs and atherosclerosis in type 2 diabetes 84
Polymorphisms of insulin receptor substrate 1 and beta3-adrenergic receptor genes in gestational diabetes and normal pregnancy 83
Advanced glycation end products: a highly complex set of biologically relevant compounds detected by mass spectrometry 81
Mass Spectrometry in the study of advanced glycation end products 80
Accurate mass measurements by Fourier trasform mass spectrometry in the study of advanced glycation end products/peptides. 80
Plasma lipoproteins, apoproteins and cardiovascular disease in type 2 diabetic patients. A nine-year follow up study 79
Biological variability of albumin excretion rate and albumin-to-cretinine ratio in hypertensive type 2 diabetic patients 78
Non-enzymatic glycation of IgG: an in vivo study 77
The general use of glycated haemoglobin for the diagnosis of diabetes and other categories of glucose intolerance: still a long way to go. 77
Off-line liquid chromatography-MALDI by with various matrices and tandem mass spectrometry for analysis of glycated human serum albumin tryptic peptides. 75
Pregnancy complicated by diabetes: what is the best level of HbA1c for conception? 74
Plasma fatty acids and lipoproteins in type 2 diabetic patients 74
Advanced glycation end-products/peptides: a preliminary investigation by LC and LC/MS 72
Pregnancy outcome in morbidly obese women before and after laparoscopic gastric banding 72
Lymphocyte subsets and cytokines in women with gestational diabetes mellitus and their newborn 71
Multivariate analysis of matrix-assisted laser desorption/ionization mass spectrometric data related to glycoxidation products of human globins in nephropathic patients 69
Diabetes and mass spectrometry 67
Hemodialysis techniques and advanced glycation end products 67
Association of Serum Cystatin C with Cardiovascular Risk Factors in Type 2 Diabetic Patients 66
Role of endogenous secretory RAGE (esRAGE) in defending against plaque formation induced by oxidative stress in type 2 diabetic patients 65
Pregnancy complicated by type 2 diabetes: An emerging problem 64
Relationship between Subclinical Diastolic Dysfunction and Lipid-and Glyco-Oxidation in Type 2 Diabetic Subjects with and without Carotid Atherosclerosis 63
A matrix-assisted laser desorption/ionization mass spectrometry study of thenon-enzymatic glycation products of human globins in diabetes 63
Further considerations on the use of Matrix-Assisted Laser Desorption Ionization Mass Spectrometry in the analysis of glycated globins 61
The role of mass spectrometry in the study of non-enzymatic protein glycation in diabetes: an update 60
Analysis of pregnancies after new IADPSG recommendation 59
Analysis of pregnancy outcomes in immigrate women with gestational diabetes 58
Prepregnancy BMI influences maternal and fetal outcomes in women with isolated gestational hyperglycaemia: a multicentre study 58
Mass spectrometic approaches in the structural identification of reaction products arising from the interaction between glucose and lysine. 55
Preprandial combination of lispro and NPH insulin improves overall blood glucose control in type I diabetic patients: A multicenter randomized crossover trial 55
Diabetes related autoimmunity in gestational diabetes mellitus: is it important? 55
Pentosidine plasma levels and relation with metabolic control in diabetic patients 55
Early detection of insulin sensitivity and beta-cell function with simple tests indicates future derangements in late pregnancy 54
Comprehensive analysis of glycated human serum albumin tryptic peptides by off-line liquid chromatograprhy followed by MALDI analysis on a time-of-flight/curved field reflectron tandem mass spectrometer 52
Patologia del cavo orale nel paziente diabetico 50
Mass spectrometric study of in vivo production of advanced glycation end-products/peptides 49
Cigarette smoking is a risk factor for nephropathy and its progression in type 2 diabetes mellitus 49
Advanced glycation end products/peptides: an in vivo investigation 48
Effect of protein leaking BK-F PMMA-based hemodialysis on plasma pentosidine levels 46
Glyoxal and methylglyoxal levels in diabetic patients: quantitative determination by a new GC/MS method. 46
Glyco-oxidation in diabetes and related diseases 46
Evaluation of T-cell receptor CD3(+) gamma delta in gestational diabetes mellitus 45
Il diabete in gravidanza 42
Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type 1 and 2 diabetic patients: the Di.N.A.S. randomized trial 42
Ruolo di endogenous secretory RAGE nelle complicanze micro-macrovascolari di un gruppo di pazienti diabetici tipo 2. 41
Antepartum and early postpartum predictors of type 2 diabetes development in women with gestational diabetes mellitus 41
New International Association of the Diabetes and Pregnancy Study Groups (IADPSG) recommendations for diagnosing gestational diabetes compared with former criteria: a retrospective study on pregnancy outcome. 41
Disordini del metabolismo dei carboidrati 40
Anticorpi anti-LDL ossidate e vasculopatia aterosclerotica in soggetti diabetici 39
Ruolo di endogenous secretory RAGE (esRAGE) nelle complicanze retiniche e macrovascolari perfieriche in un gruppo di pazienti diabetici di tipo 2. 36
Evaluation of diagnostic reability of DCA 2000 for rapid and simple monitoring of HbA1c 33
Predittori di microalbuminuria nel Diabete Tipo 2 32
DENSITA' SCHELETRICA E METABOLISMO MINERALE IN PAZIENTI CON DIABETE MELLITO 32
Ipo e iper-glicemia: stimolo infiammatorio per i monociti circolanti. 28
Diabete e gravidanza 28
Insulin terapy in pregnancy complicated by diabetes: are insulin analogs a new tool? 25
Totale 5.198
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.139
article - articoli 14.062
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 492
Totale 29.693
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019415 0 0 0 0 0 0 0 0 0 102 174 139
2019/20201.138 188 31 19 89 109 103 94 139 103 139 57 67
2020/2021920 28 70 7 71 56 117 21 73 156 93 103 125
2021/2022910 15 89 143 52 37 30 31 108 39 13 136 217
2022/2023758 177 82 54 58 125 105 0 50 75 5 25 2
2023/2024230 10 38 42 29 24 50 20 6 6 5 0 0
Totale 5.198